Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS guidance · 2015-10-21Clinical Trial Update: Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial
Clinical trial update describing considerations for patients in a Phase I treatment trial when deciding whether to participate in pharmacoki…
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies [Phase 1]
Phase 1 trial evaluating belinostat in combination with warfarin in patients with solid tumors or hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-21Clinical Trial Update: Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment [Phase 1]
Phase 1 safety and pharmacokinetic study of cabazitaxel in patients with advanced solid tumors and liver impairment.
-
CLINICAL_TRIALS trial_result · 2015-07-14Clinical Trial Update: Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant
This clinical trial update reports on immune reconstitution in oncology patients following autologous stem cell transplantation.
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer [Phase 1]
Phase 1 trial evaluating veliparib with carboplatin and paclitaxel in adults with advanced solid tumors has completed. The study included BR…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency [Phase 4]
Phase 4 randomized trial evaluating erythropoiesis-stimulating agents with ferric carboxymaltose in cancer patients with functional iron def…
-
CLINICAL_TRIALS withdrawal · 2015-02-18Clinical Trial Update: Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease [Phase 4]
Phase 4 clinical trial evaluating time associated with preparation and administration of denosumab and pamidronate in patients with solid tu…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors [Phase 2]
Phase 2 trial evaluating benazepril, lisinopril, ramipril, or losartan for hypertension in patients with solid tumors; study terminated with…
-
CLINICAL_TRIALS withdrawal · 2014-12-11Clinical Trial Update: Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors [NA]
This clinical trial update indicates that Vanderbilt University’s study on early enteral tube feedings for children undergoing chemotherapy …
-
CLINICAL_TRIALS research · 2014-10-02Clinical Trial Update: A Study: Pure CBD as Single-agent for Solid Tumor. [Phase 2]
A Phase 2 clinical trial evaluating pure cannabidiol (CBD) as a single agent for solid tumors; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes [Phase 2]
Phase 2 study of ramucirumab (Cyramza) assesses QTc interval changes; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated [Phase 1]
Phase 1 trial update of TRC105 with standard-dose bevacizumab in adults with solid tumors indicated for bevacizumab.
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Aflibercept in Treating Young Patients With Relapsed or Refractory Solid Tumors [Phase 1]
Phase 1 trial of aflibercept in relapsed or refractory pediatric solid tumors completed; safety and pharmacokinetic data reported.
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors [Phase 1]
This document reports the completion of a Phase 1 trial of pemetrexed disodium in young patients with recurrent solid tumors; the snippet do…
-
CLINICAL_TRIALS trial_result · 2014-01-01Clinical Trial Update: A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation [Phase 2]
Phase 2 study comparing non-myeloablative Flu-TBI conditioning with reduced-intensity Flu-BU-ATG conditioning in allogeneic transplantation …
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms [Phase 1]
Phase 1 trial evaluating the combination of RAD001 and CP-751,871 in patients with advanced sarcomas and other malignant neoplasms has compl…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Safety Study of CALAA-01 to Treat Solid Tumor Cancers [Phase 1]
Phase 1 safety study of CALAA-01 in solid tumor cancers has been terminated, according to a clinical trials update.
-
CLINICAL_TRIALS trial_result · 2013-09-27Clinical Trial Update: To Determine the Maximum Tolerated Dose (MTD) of BIBF 1120 in Patients With Solid Tumours [Phase 1]
Phase 1 trial to determine the maximum tolerated dose of BIBF 1120 in patients with malignant solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-19Clinical Trial Update: Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor [Phase 1]
Phase 1 clinical trial evaluating allogeneic natural killer (NK) cell therapy in patients with malignant lymphomas or solid tumors has compl…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma [NA]
This clinical trial update reports on MP470 for unresectable or metastatic solid tumors and lymphoma, with the study status shown as termina…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors [Phase 1]
A Phase 1 trial update reports the completion of donor stem cell transplant studies in young patients with relapsed or refractory solid tumo…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia [Phase 1]
Phase 1 clinical trial evaluating safety and dosing of 17-N-allylamino-17-demethoxygeldanamycin (tanespimycin) in pediatric patients with re…
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Study of @neWorld: A Virtual Community for Children With Cancer [Phase 1, Phase 2]
This entry provides an update on the neWorld study, a virtual community for children with cancer. It indicates completion of Phase 1 and Pha…
-
CLINICAL_TRIALS trial_result · 2013-05-10Clinical Trial Update: Study of RH-1 in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
This clinical trial update indicates that the Phase 1 study of RH-1 in patients with advanced solid tumors and Non-Hodgkin's lymphoma has be…
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
This entry reports the completion of a Phase 1 study evaluating Oral OSI-027 in patients with advanced solid tumors or lymphoma.